Marcus & Millichap, Inc. (NYSE:MMI – Get Free Report) COO John David Parker sold 1,835 shares of the firm’s stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $35.29, for a total transaction of $64,757.15. Following the completion of the sale, the chief operating officer now owns 13,373 shares of the company’s stock, valued at approximately $471,933.17. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
John David Parker also recently made the following trade(s):
- On Thursday, March 14th, John David Parker sold 9,716 shares of Marcus & Millichap stock. The shares were sold at an average price of $32.83, for a total transaction of $318,976.28.
Marcus & Millichap Trading Down 0.6 %
Shares of MMI opened at $33.33 on Friday. Marcus & Millichap, Inc. has a 1-year low of $26.81 and a 1-year high of $44.24. The company has a 50-day moving average of $32.95 and a 200 day moving average of $35.59.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of Marcus & Millichap from a “sell” rating to a “hold” rating in a report on Monday, May 13th.
View Our Latest Report on Marcus & Millichap
Marcus & Millichap Company Profile
Marcus & Millichap, Inc, an investment brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing, as well as capital markets.
Read More
- Five stocks we like better than Marcus & Millichap
- Options Trading – Understanding Strike Price
- Micron Stock: Even With A 150% Gain, Analysts Want More
- How to Invest in the Best Canadian StocksĀ
- TD Bank Q2 Earnings: Record Highs and Regulatory Hurdles
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Medtronic Dips: Is Now the Time to Buy?
Receive News & Ratings for Marcus & Millichap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marcus & Millichap and related companies with MarketBeat.com's FREE daily email newsletter.